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Abstract 
Background: Overuse of antibiotics is a major challenge and undermines measures to control drug resistance 
worldwide. Postnatal women and newborns are at risk of infections and are often prescribed prophylactic antibiotics 
although there is no evidence to support their universal use in either group.
Methods: We performed point prevalence surveys in three hospitals in Dar es Salaam, Tanzania, in 2018 to collect 
descriptive data on antibiotic use and infections, in maternity and neonatal wards.
Results: Prescribing of antibiotics was high in all three hospitals ranging from 90% (43/48) to 100% (34/34) in women 
after cesarean section, from 1.4% (1/73) to 63% (30/48) in women after vaginal delivery, and from 89% (76/85) to 100% 
(77/77) in neonates. The most common reason for prescribing antibiotics was medical prophylaxis in both maternity 
and neonatal wards.
Conclusions: We observed substantial overuse of antibiotics in postnatal women and newborns. This calls for urgent 
antibiotic stewardship programs in Tanzanian hospitals to curb this inappropriate use and limit the spread of antimi-
crobial resistance.
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Background
Overuse of antibiotics is a major challenge worldwide 
and undermines measures to control antimicrobial resist-
ance (AMR). Failure to control AMR is leading to an 
increase in mortality, prolonged hospital stays, worsening 
of clinical conditions and increase in the cost for treat-
ments [1–3]. AMR and specifically, resistance to anti-
biotic agents for treating bacterial infections, is a major 
problem in many African countries [4–6]. In Tanzania, 
an AMR surveillance platform has recently been imple-
mented, but the extent of the burden of AMR currently 
remains unknown [7, 8]. Overuse (too much use), misuse 
(wrong use) or high consumption (use of large quantities) 
of antimicrobial drugs are closely related concepts. Col-
lectively, these are major drivers of antimicrobial resist-
ance [3, 9].
There are multiple reports of high levels of unnecessary 
prescriptions of antibiotics for both postnatal women, 
following either cesarean section (CS) or vaginal deliv-
ery, and neonates [10–13]. In Sub-Saharan Africa (SSA), 
although the risk of perinatal infections is high for both 
mothers and neonates, limited data exists on the use of 
antibiotics in these groups [14].
Similarly, in Tanzania there are few formal studies of 
prescribing practices for antibiotics during the postpar-
tum and neonatal period, where maternal and neonatal 
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sepsis are estimated to be responsible for 13% and 20% 
mortality respectively [15, 16]. As part of a pilot study 
investigating impacts of an environmental hygiene inter-
vention in Tanzanian hospitals, we aimed to describe 
antibiotic use in women who recently gave birth and their 
newborns in three hospitals in Dar es Salaam, Tanzania.
Methods
Study design and setting
We conducted point prevalence surveys (PPS) of health-
care-associated infection (HAI) and antibiotic use in 
maternity, gynecological and neonatal wards as part of 
the CLEAN study (July 2018–May 2019), a pilot evalu-
ation of an environmental hygiene training interven-
tion [17]. The rounds of the PPS were conducted once 
a month between October and December 2018. We 
describe the results of antibiotic use in these hospitals. 
The surveys were conducted in three public-sector hos-
pitals in Dar es Salaam, Tanzania. Tanzania is an East 
African country with a population of more than 40 mil-
lion and is graded lower-middle income by gross national 
income (GNI), human asset and economic vulnerability 
development [18, 19]. All three hospitals in this study 
have separate post-natal wards for vaginal delivery and 
CS, Hospital 1 and 2 have neonatal wards, while Hospital 
3 refers sick newborns to Hospital 2. In 2017, the average 
number of deliveries per month per hospital was; Hospi-
tal 1-1393; Hospital 2-1125 and Hospital 3-1089.
Data collection procedure
Two doctors from each hospital’s Obstetric Depart-
ment were trained in how to collect PPS data. They con-
ducted the survey on one weekday per month for three 
consecutive months, with direct supervision from one 
investigator (AMK). Data were collected on structured 
questionnaires adapted from the European Centre for 
Disease Prevention and Control (ECDC) PPS proto-
col [20].This tool was originally designed to evaluate the 
prevalence of HAI in European healthcare facilities [20], 
and this also captures information on current inpatient 
antibiotic use. Data were collected at the level of the hos-
pital, ward and individual patient. For individual patients, 
details of age, sex, date of admission, the presence of 
an active infection and whether the patient had been 
given an antimicrobial within the past 24 h of admission 
were collected. Identifying information including name, 
address and date of delivery were not collected. These 
data were extracted from the individual patient case-
notes. The reason for prescribing antibiotics was taken 
from the case notes. If no explanation was provided, it 
was recorded as “indication unclear”. The paper-based 
questionnaires were stored in a locked cabinet at the 
study office. The database was encrypted with a password 
and only the study data clerk and statistician accessed the 
data.
Analysis
Data entry and initial cleaning was done in the Helic-
sWin.NeT version no 2.4, the recommended software for 
the analysis of the PPS in the ECDC protocol. Further 
cleaning and data analysis were conducted in Stata ver-
sion 14.1. For each ward, the prevalence of antibiotic use 
was calculated as the percentage of total patients on anti-
biotics admitted in the ward at the time of the survey.
Results
Admission
We collected data from a total of 376 mothers and 162 
newborns across three rounds of the PPS in each hos-
pital. Hospital 1 had a total of 173 mothers and 77 new-
borns, hospital 2 had 258 mothers and 85 newborns, 
while hospital 3 had 107 mothers only.
Maternal antibiotic use
The use of antibiotics in CS wards was extremely high: 
90% (43/48) of patients in Hospital 1, 96% (45/47) in Hos-
pital 2 and 100% (34/34) in Hospital 3. In Hospital 1, all 
mothers with suspected infections were transferred to 
the gynecology ward, thus all the antibiotics prescribed 
in CS ward were for post-operative surgical prophylaxis. 
At Hospital 2, only four out of 45 mothers on antibi-
otic treatment were reported to have active infection; 
one with deep surgical site infection (SSI) (first survey) 
and three with superficial SSI (third survey). All other 
women (91%; 41/45) were receiving antibiotics for post-
operative surgical prophylaxis. In Hospital 3, all admitted 
mothers (100%; 34/34) were on antibiotics. One SSI was 
reported in the first survey, but all other antibiotics were 
prescribed for surgical prophylaxis (see Table  1). In the 
post-natal vaginal delivery wards, antibiotic use varied 
considerably between hospitals and over time. The over-
all use of antibiotics was 63% (30/48) at Hospital 1, 11% 
(14/126) at Hospital 2, and 1.4% (1/73) at Hospital 3. At 
Hospital 1, use of antibiotics increased from 18% (2/11) 
in the first survey to 100% (22/22) in the third survey; 
all antibiotics were prescribed for medical prophylaxis. 
At Hospital 2, 11% (14/126) were prescribed antibiotics. 
Out of these, 7% (1/14) were for hospital-acquired episi-
otomy infection, 7% (1/14) were for community-acquired 
infection, 57% (8/14) were for medical prophylaxis and 
the remainder 29% (4/14) were without clear indications. 
At Hospital 3, only one woman (1.4%;1/73) was receiv-
ing antibiotics which was for surgical prophylaxis (see 
Table 2.)
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Neonatal antibiotic use
All newborns (77/77) in Hospital 1 were receiving anti-
biotics; 17% (13/77) had HAI, 1.3% (1/77) had com-
munity-acquired infection, and the rest (82%; 63/77) 
were being given antibiotics for medical prophylaxis. 
In Hospital 2, 89% (76/85) were receiving antibiotics 
across all three rounds of the survey, increasing from 
80% (24/30) during the first round to 100% (28/28) in 
the third round. Out of 76 newborns on antibiotics, 4% 
(3/76) had community-acquired infections, 40% (30/76) 
had HAI and 57% (43/76) had no clear indication for 
antibiotic use (see Table 3).
Discussion
We performed repeated rounds of PPS for antibiotic use 
in the maternity and neonatal departments of three busy 
public sector hospitals in urban Tanzania. We found high 
levels of antibiotic use in women following vaginal deliv-
ery or caesarean section. Around 95% of surveyed women 
who had CS were receiving antibiotics, and among these, 
95% were receiving them for post-operative surgical 
prophylaxis lasting more than one day. The high use was 
observed in all three hospitals and in all surveys. Pre-
scription of antibiotics in post-natal wards varied widely 
between hospitals: while Hospital 1 prescribed antibiotics 
Table 1 Prevalence of antibiotic use on caesarean section wards
Hospital Survey round Total mothers Mothers on 
antibiotics n (%)










Hospital 1 1 16 15 (93.8) 0 0 15 (100) 0
2 15 11 (83.3) 0 0 11 (100) 0
3 17 17 (100) 0 0 17 (100) 0
Total 48 43 (89.5) 0 0 43 (100) 0
Hospital 2 1 17 16 (94.1) 0 1 (6.3) 15 (93.7) 0
2 15 14 (93.3) 0 0 14 (100) 0
3 15 15 (100) 0 3 (20) 12 (80) 0
Total 47 45 (95.8) 0 4 (8.9) 41 (91.1) 0
Hospital 3 1 11 11 (100) 0 1 (9.1) 10 (90.9) 0
2 11 11 (100) 0 0 11 (100) 0
3 12 12 (100) 0 0 12 (100) 0
Total 34 34 (100) 0 1 (2.9) 33 (97.1) 0
Table 2 Prevalence of antibiotic use on post-natal wards
Hospital Survey round Total mothers Mothers on 
antibiotics n (%)









Hospital 1 1 11 2 (18.2) 0 0 2 (100) 0
2 15 6 (40.0) 0 0 6 (100) 0
3 22 22 (100) 0 0 22 (100) 0
Total 48 30 (62.5) 0 0 30 (100) 0
Hospital 2 1 36 6 (16.7) 1 (16.7) 1 (16.7) 4 (66.6) 0
2 45 4 (8.9) 0 0 4 (100) 0
3 45 4 (8.9) 0 0 0 4 (100)
Total 126 14 (11.1) 1 (7.1) 1 (7.1) 8 (57.2) 4 (28.6)
Hospital 3 1 20 1 (5) 0 0 1 (100) 0
2 26 0 0 0 0 0
3 27 0 0 0 0 0
Total 73 1 (1.4) 0 0 1 (100) 0
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in about 60% of women, Hospitals 2 and 3 only prescribed 
11% and 1.4% respectively. The most common reasons for 
antibiotic prescription were medical or surgical prophy-
laxis in all hospitals. Similarly, we observed high use of 
antibiotics, at around 90%, in neonatal wards, with the 
vast majority being used for medical prophylaxis or 
without a clear indication. This near-universal prescrip-
tion of antibiotics after CS is a common clinical practice 
in low income countries [21–23], despite the absence of 
evidence or recommendations to support it. By contrast, 
in high income countries, the irrational use of antibiot-
ics after CS and in maternity wards is reported to have 
dropped markedly over recent years [10]. This variation 
in practice may be explained by the onset of antibiotic 
stewardship programs in many hospitals in high-income 
countries [24]. In hospitals with limited resources, pre-
scribing post-operative prophylactic antibiotics is likely 
to be influenced by concerns about high local rates of 
SSI, in turn attributable to weak measures for infection 
prevention and poor hygiene in surgical environments 
[25]. However, to the best of our knowledge there is no 
evidence that post-operative antibiotic prophylaxis helps 
to prevent surgical site infections. In Tanzania, infection 
prevention and control (IPC) data from health facili-
ties indicates low adherence to IPC guidelines among 
health care workers [25, 26]. In this study, antibiotics 
were prescribed to one quarter of women with vaginal 
delivery, with substantial variation between the facili-
ties. The highest use was reported in Hospital 1 (62.5%), 
most commonly for prophylaxis, whereas antibiotic use 
was relatively low for women following vaginal delivery 
in Hospital 2 (11.1%) and Hospital 3 (1.4%). We believe 
this wide variation between hospitals is likely to reflect 
differences in prescribing practices between the facilities 
or individual health care workers, rather than differences 
in infection rates, though we cannot conclusively confirm 
this. In other low-income settings, high use of antibiot-
ics in women with vaginal delivery has been reported in 
India and Vietnam, and in a WHO study combined data 
from Africa, Asia and the Americas [12, 23, 26].While 
the study in India reported the lack of local guidelines at 
the time of the study as a possible factor underlying the 
high antibiotic prescribing rate, it was not clear whether 
the Vietnamese and WHO studies were in facilities with 
availability of guidelines for management. On the other 
hand, studies from Sweden and USA have reported a 
low use of antibiotics after vaginal delivery, reflecting the 
well-established nature of antibiotic stewardship pro-
grams in these countries [10, 23, 28].
In this study, we expected to see a difference in anti-
biotic use between the CS and vaginal delivery because 
CS carries higher risk of infection. Prophylactic antibi-
otics are recommended in CS but they should be given 
pre-rather than post-operatively. Irrational overuse of 
antibiotics is likely to ultimately lead to severe illness and 
death in mothers and newborns as a result of increas-
ing levels of antibiotic resistance in low-income coun-
tries [3]. More than 90% of the admitted neonates were 
given antibiotics during this survey, typically as medical 
prophylaxis or without a clearly recorded indication. The 
wards were staffed by pediatricians and general practi-
tioners, and it is possible that prescribing practice would 
be different among specialist neonatologists. However, 
specialists are rare for regional hospitals in Tanzania, so 
we believe our findings would be generalizable to other 
hospitals in Tanzania. Similarly, high use of antibiotics in 
neonates has been reported in one study in India where 
around 90% of the admitted neonates were given antibi-
otics [27]. Use of antibiotics in high-income countries is 
reported to have dropped significantly in the past years 
among neonates [28]. Early neonatal antibiotic expo-
sure may be associated with morbidities such as allergy, 
Table 3 Prevalence of antibiotic use on neonatal wards
There was no inpatient neonatal ward in Hospital 3 at the time of survey













Hospital 1 1 33 33 (100) 1 (3.0) 13 (39.4) 19 (57.6) 0
2 26 26 (100) 0 0 26 (100) 0
3 18 18 (100) 0 0 18 (100) 0
Total 77 77 (100) 1 (1.3) 13 (16.9) 63 (81.8) 0
Hospital 2 1 30 24 (80.0) 1 (4.2) 11 (45.8) 0 12 (50)
2 27 24 (88.9) 1 (4.2) 9 (37.5) 0 14 (58.3)
3 28 28 (100) 1 (3.6) 10 (35.7) 0 17 (60.7)
Total 85 76 (89.4) 3 (4) 30 (39.5) 0 43 (56.5)
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obesity, gastrointestinal disorders and acquisition of car-
riage of antibiotic resistant bacteria, though the underly-
ing evidence is weak [29–31].
Study limitations
The findings in this study might have been subjected to 
a form of Hawthorne effect since the clinicians involved 
in the data collection were also working on the maternity 
wards and prescribing antibiotics to postnatal women. It 
is therefore possible that performing the survey increased 
their concern about infections and could have influenced 
their prescribing practice in later rounds of the survey. 
This may partly explain the increase in prescribing seen 
at Hospital 1 during the course of the study.
Conclusion
There was an extremely high prevalence of antibiotic pre-
scribing for prophylaxis in maternal and neonatal units 
in hospitals in Dar es Salaam, Tanzania. Better infection 
control policies, local and national guidelines, and anti-
microbial stewardship programs need to be implemented 
to avoid unnecessary prescription of the antibiotics and 
promotion of antibiotic resistance.
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